APO Research
Talk to an analyst

APO RESEARCH · REPORT

Systemic Mastocytosis Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Systemic Mastocytosis Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025195 pages

Choose your research edition.

Industry ResearchSystemic Mastocytosis Treatment Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Systemic Mastocytosis Treatment Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Systemic Mastocytosis Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Systemic Mastocytosis Treatment Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Systemic Mastocytosis Treatment Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Systemic Mastocytosis Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Systemic Mastocytosis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Systemic Mastocytosis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Systemic Mastocytosis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Systemic Mastocytosis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Systemic Mastocytosis Treatment include Novartis AG, AbbVie Inc, Stemline Therapeutics Inc, Seattle Genetics Inc, Patara Pharma Inc, Deciphera Pharmaceuticals LLC, Bristol-Myers Squibb Company, Blueprint Medicines Corp and Arog Pharmaceuticals Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Systemic Mastocytosis Treatment market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Systemic Mastocytosis Treatment and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Systemic Mastocytosis Treatment sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Systemic Mastocytosis Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Systemic Mastocytosis Treatment Segment by Company

Novartis AG

AbbVie Inc

Stemline Therapeutics Inc

Seattle Genetics Inc

Patara Pharma Inc

Deciphera Pharmaceuticals LLC

Bristol-Myers Squibb Company

Blueprint Medicines Corp

Arog Pharmaceuticals Inc

AB Science SA

Systemic Mastocytosis Treatment Segment by Type

Cromolyn Sodium

Brentuximab Vedotin

Crenolanib Besylate

BLU-285

AK-002

Others

Systemic Mastocytosis Treatment Segment by Application

Homecare

Hospital

Clinic

Systemic Mastocytosis Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Systemic Mastocytosis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Systemic Mastocytosis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Systemic Mastocytosis Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Systemic Mastocytosis Treatment market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Systemic Mastocytosis Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Systemic Mastocytosis Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Systemic Mastocytosis Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Systemic Mastocytosis Treatment Industry Trends Table 2. Systemic Mastocytosis Treatment Industry Drivers Table 3. Systemic Mastocytosis Treatment Industry Opportunities and Challenges Table 4. Systemic Mastocytosis Treatment Industry Restraints Table 5. Global Systemic Mastocytosis Treatment Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Systemic Mastocytosis Treatment Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Systemic Mastocytosis Treatment Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Systemic Mastocytosis Treatment Sales Market Share by Manufacturers Table 9. Global Systemic Mastocytosis Treatment Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Systemic Mastocytosis Treatment Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Systemic Mastocytosis Treatment Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Systemic Mastocytosis Treatment Manufacturers, Product Type & Application Table 13. Global Systemic Mastocytosis Treatment Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Systemic Mastocytosis Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Cromolyn Sodium Table 17. Major Manufacturers of Brentuximab Vedotin Table 18. Major Manufacturers of Crenolanib Besylate Table 19. Major Manufacturers of BLU-285 Table 20. Major Manufacturers of AK-002 Table 21. Major Manufacturers of Others Table 22. Global Systemic Mastocytosis Treatment Sales by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Systemic Mastocytosis Treatment Sales by Type (2021-2026) & (k units) Table 24. Global Systemic Mastocytosis Treatment Sales by Type (2027-2032) & (k units) Table 25. Global Systemic Mastocytosis Treatment Sales Market Share by Type (2021-2026) Table 26. Global Systemic Mastocytosis Treatment Sales Market Share by Type (2027-2032) Table 27. Global Systemic Mastocytosis Treatment Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 28. Global Systemic Mastocytosis Treatment Revenue by Type (2021-2026) & (k units) Table 29. Global Systemic Mastocytosis Treatment Revenue by Type (2027-2032) & (k units) Table 30. Global Systemic Mastocytosis Treatment Revenue Market Share by Type (2021-2026) Table 31. Global Systemic Mastocytosis Treatment Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Homecare Table 33. Major Manufacturers of Hospital Table 34. Major Manufacturers of Clinic Table 35. Global Systemic Mastocytosis Treatment Sales by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Systemic Mastocytosis Treatment Sales by Application (2021-2026) & (k units) Table 37. Global Systemic Mastocytosis Treatment Sales by Application (2027-2032) & (k units) Table 38. Global Systemic Mastocytosis Treatment Sales Market Share by Application (2021-2026) Table 39. Global Systemic Mastocytosis Treatment Sales Market Share by Application (2027-2032) Table 40. Global Systemic Mastocytosis Treatment Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Systemic Mastocytosis Treatment Revenue by Application (2021-2026) & (k units) Table 42. Global Systemic Mastocytosis Treatment Revenue by Application (2027-2032) & (k units) Table 43. Global Systemic Mastocytosis Treatment Revenue Market Share by Application (2021-2026) Table 44. Global Systemic Mastocytosis Treatment Revenue Market Share by Application (2027-2032) Table 45. Global Systemic Mastocytosis Treatment Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Systemic Mastocytosis Treatment Sales by Region (2021-2026) & (k units) Table 47. Global Systemic Mastocytosis Treatment Sales Market Share by Region (2021-2026) Table 48. Global Systemic Mastocytosis Treatment Sales Forecasted by Region (2027-2032) & (k units) Table 49. Global Systemic Mastocytosis Treatment Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Systemic Mastocytosis Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. North America Systemic Mastocytosis Treatment Sales by Country (2021-2026) & (k units) Table 52. North America Systemic Mastocytosis Treatment Sales by Country (2027-2032) & (k units) Table 53. Europe Systemic Mastocytosis Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Europe Systemic Mastocytosis Treatment Sales by Country (2021-2026) & (k units) Table 55. Europe Systemic Mastocytosis Treatment Sales by Country (2027-2032) & (k units) Table 56. Asia Pacific Systemic Mastocytosis Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Asia Pacific Systemic Mastocytosis Treatment Sales by Country (2021-2026) & (k units) Table 58. Asia Pacific Systemic Mastocytosis Treatment Sales by Country (2027-2032) & (k units) Table 59. South America, Middle East and Africa Systemic Mastocytosis Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 60. South America, Middle East and Africa Systemic Mastocytosis Treatment Sales by Country (2021-2026) & (k units) Table 61. South America, Middle East and Africa Systemic Mastocytosis Treatment Sales by Country (2027-2032) & (k units) Table 62. Global Systemic Mastocytosis Treatment Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Systemic Mastocytosis Treatment Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Systemic Mastocytosis Treatment Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Systemic Mastocytosis Treatment Revenue Market Share by Region (2021-2026) Table 66. Global Systemic Mastocytosis Treatment Revenue Market Share by Region (2027-2032) Table 67. Novartis AG Company Information Table 68. Novartis AG Business Overview Table 69. Novartis AG Systemic Mastocytosis Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Novartis AG Systemic Mastocytosis Treatment Product Portfolio Table 71. Novartis AG Recent Development Table 72. AbbVie Inc Company Information Table 73. AbbVie Inc Business Overview Table 74. AbbVie Inc Systemic Mastocytosis Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. AbbVie Inc Systemic Mastocytosis Treatment Product Portfolio Table 76. AbbVie Inc Recent Development Table 77. Stemline Therapeutics Inc Company Information Table 78. Stemline Therapeutics Inc Business Overview Table 79. Stemline Therapeutics Inc Systemic Mastocytosis Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Stemline Therapeutics Inc Systemic Mastocytosis Treatment Product Portfolio Table 81. Stemline Therapeutics Inc Recent Development Table 82. Seattle Genetics Inc Company Information Table 83. Seattle Genetics Inc Business Overview Table 84. Seattle Genetics Inc Systemic Mastocytosis Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Seattle Genetics Inc Systemic Mastocytosis Treatment Product Portfolio Table 86. Seattle Genetics Inc Recent Development Table 87. Patara Pharma Inc Company Information Table 88. Patara Pharma Inc Business Overview Table 89. Patara Pharma Inc Systemic Mastocytosis Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Patara Pharma Inc Systemic Mastocytosis Treatment Product Portfolio Table 91. Patara Pharma Inc Recent Development Table 92. Deciphera Pharmaceuticals LLC Company Information Table 93. Deciphera Pharmaceuticals LLC Business Overview Table 94. Deciphera Pharmaceuticals LLC Systemic Mastocytosis Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Deciphera Pharmaceuticals LLC Systemic Mastocytosis Treatment Product Portfolio Table 96. Deciphera Pharmaceuticals LLC Recent Development Table 97. Bristol-Myers Squibb Company Company Information Table 98. Bristol-Myers Squibb Company Business Overview Table 99. Bristol-Myers Squibb Company Systemic Mastocytosis Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Bristol-Myers Squibb Company Systemic Mastocytosis Treatment Product Portfolio Table 101. Bristol-Myers Squibb Company Recent Development Table 102. Blueprint Medicines Corp Company Information Table 103. Blueprint Medicines Corp Business Overview Table 104. Blueprint Medicines Corp Systemic Mastocytosis Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Blueprint Medicines Corp Systemic Mastocytosis Treatment Product Portfolio Table 106. Blueprint Medicines Corp Recent Development Table 107. Arog Pharmaceuticals Inc Company Information Table 108. Arog Pharmaceuticals Inc Business Overview Table 109. Arog Pharmaceuticals Inc Systemic Mastocytosis Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Arog Pharmaceuticals Inc Systemic Mastocytosis Treatment Product Portfolio Table 111. Arog Pharmaceuticals Inc Recent Development Table 112. AB Science SA Company Information Table 113. AB Science SA Business Overview Table 114. AB Science SA Systemic Mastocytosis Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. AB Science SA Systemic Mastocytosis Treatment Product Portfolio Table 116. AB Science SA Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Systemic Mastocytosis Treatment Distributors List Table 120. Systemic Mastocytosis Treatment Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Systemic Mastocytosis Treatment Product Image Figure 2. Global Systemic Mastocytosis Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Systemic Mastocytosis Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Systemic Mastocytosis Treatment Sales (2021-2032) & (k units) Figure 5. Global Systemic Mastocytosis Treatment Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Systemic Mastocytosis Treatment Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Cromolyn Sodium Image Figure 9. Brentuximab Vedotin Image Figure 10. Crenolanib Besylate Image Figure 11. BLU-285 Image Figure 12. AK-002 Image Figure 13. Others Image Figure 14. Global Systemic Mastocytosis Treatment Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Systemic Mastocytosis Treatment Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Systemic Mastocytosis Treatment Sales Market Share by Type (2021-2032) Figure 17. Global Systemic Mastocytosis Treatment Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 18. Global Systemic Mastocytosis Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Systemic Mastocytosis Treatment Revenue Market Share by Type (2021-2032) Figure 20. Homecare Image Figure 21. Hospital Image Figure 22. Clinic Image Figure 23. Global Systemic Mastocytosis Treatment Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Systemic Mastocytosis Treatment Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Systemic Mastocytosis Treatment Sales Market Share by Application (2021-2032) Figure 26. Global Systemic Mastocytosis Treatment Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Systemic Mastocytosis Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Systemic Mastocytosis Treatment Revenue Market Share by Application (2021-2032) Figure 29. North America Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 30. North America Systemic Mastocytosis Treatment Sales Market Share by Country (2021-2032) Figure 31. U.S. Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 32. Canada Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 33. Mexico Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Systemic Mastocytosis Treatment Sales Market Share by Country (2021-2032) Figure 36. Germany Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 37. France Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 38. U.K. Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 39. Italy Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 40. Netherlands Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Systemic Mastocytosis Treatment Sales Market Share by Country (2021-2032) Figure 43. China Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 44. Japan Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 45. South Korea Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 46. Southeast Asia Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 47. India Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 48. Australia Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Systemic Mastocytosis Treatment Sales Market Share by Country (2021-2032) Figure 51. Brazil Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 52. South Africa Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 53. Saudi Arabia Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 54. Turkey Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 55. Argentina Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 56. UAE Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 57. Egypt Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 58. Chile Systemic Mastocytosis Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 59. Global Systemic Mastocytosis Treatment Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Systemic Mastocytosis Treatment Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Systemic Mastocytosis Treatment Revenue (2021-2032) & (US$ Million) Figure 62. North America Systemic Mastocytosis Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Systemic Mastocytosis Treatment Revenue (2021-2032) & (US$ Million) Figure 64. Europe Systemic Mastocytosis Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Systemic Mastocytosis Treatment Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Systemic Mastocytosis Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Systemic Mastocytosis Treatment Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Systemic Mastocytosis Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Systemic Mastocytosis Treatment Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Systemic Mastocytosis Treatment Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Cromolyn Sodium
  • Brentuximab Vedotin
  • Crenolanib Besylate
  • BLU-285
  • AK-002
  • Others
Applications
  • Homecare
  • Hospital
  • Clinic
Companies covered
  • Novartis AG
  • AbbVie Inc
  • Stemline Therapeutics Inc
  • Seattle Genetics Inc
  • Patara Pharma Inc
  • Deciphera Pharmaceuticals LLC
  • Bristol-Myers Squibb Company
  • Blueprint Medicines Corp
  • Arog Pharmaceuticals Inc
  • AB Science SA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Systemic Mastocytosis Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Systemic Mastocytosis Treatment Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Systemic Mastocytosis Treatment Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Systemic Mastocytosis Treatment Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Systemic Mastocytosis Treatment Market Dynamics
  1. 2.1 Systemic Mastocytosis Treatment Industry Trends
  2. 2.2 Systemic Mastocytosis Treatment Industry Drivers
  3. 2.3 Systemic Mastocytosis Treatment Industry Opportunities and Challenges
  4. 2.4 Systemic Mastocytosis Treatment Industry Restraints
3 Systemic Mastocytosis Treatment Market by Manufacturers
  1. 3.1 Global Systemic Mastocytosis Treatment Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Systemic Mastocytosis Treatment Sales by Manufacturers (2021-2026)
  3. 3.3 Global Systemic Mastocytosis Treatment Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Systemic Mastocytosis Treatment Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Systemic Mastocytosis Treatment Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Systemic Mastocytosis Treatment Manufacturers, Product Type & Application
  7. 3.7 Global Systemic Mastocytosis Treatment Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Systemic Mastocytosis Treatment Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Systemic Mastocytosis Treatment Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Systemic Mastocytosis Treatment Tier 1, Tier 2, and Tier 3
4 Systemic Mastocytosis Treatment Market by Type
  1. 4.1 Systemic Mastocytosis Treatment Type Introduction
  2. 4.1.1 Cromolyn Sodium
  3. 4.1.2 Brentuximab Vedotin
  4. 4.1.3 Crenolanib Besylate
  5. 4.1.4 BLU-285
  6. 4.1.5 AK-002
  7. 4.1.6 Others
  8. 4.2 Global Systemic Mastocytosis Treatment Sales by Type
  9. 4.2.1 Global Systemic Mastocytosis Treatment Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Systemic Mastocytosis Treatment Sales by Type (2021-2032)
  11. 4.2.3 Global Systemic Mastocytosis Treatment Sales Market Share by Type (2021-2032)
  12. 4.3 Global Systemic Mastocytosis Treatment Revenue by Type
  13. 4.3.1 Global Systemic Mastocytosis Treatment Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Systemic Mastocytosis Treatment Revenue by Type (2021-2032)
  15. 4.3.3 Global Systemic Mastocytosis Treatment Revenue Market Share by Type (2021-2032)
5 Systemic Mastocytosis Treatment Market by Application
  1. 5.1 Systemic Mastocytosis Treatment Application Introduction
  2. 5.1.1 Homecare
  3. 5.1.2 Hospital
  4. 5.1.3 Clinic
  5. 5.2 Global Systemic Mastocytosis Treatment Sales by Application
  6. 5.2.1 Global Systemic Mastocytosis Treatment Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Systemic Mastocytosis Treatment Sales by Application (2021-2032)
  8. 5.2.3 Global Systemic Mastocytosis Treatment Sales Market Share by Application (2021-2032)
  9. 5.3 Global Systemic Mastocytosis Treatment Revenue by Application
  10. 5.3.1 Global Systemic Mastocytosis Treatment Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Systemic Mastocytosis Treatment Revenue by Application (2021-2032)
  12. 5.3.3 Global Systemic Mastocytosis Treatment Revenue Market Share by Application (2021-2032)
6 Global Systemic Mastocytosis Treatment Sales by Region
  1. 6.1 Global Systemic Mastocytosis Treatment Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Systemic Mastocytosis Treatment Sales by Region (2021-2032)
  3. 6.2.1 Global Systemic Mastocytosis Treatment Sales by Region (2021-2026)
  4. 6.2.2 Global Systemic Mastocytosis Treatment Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Systemic Mastocytosis Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Systemic Mastocytosis Treatment Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Systemic Mastocytosis Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Systemic Mastocytosis Treatment Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Systemic Mastocytosis Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Systemic Mastocytosis Treatment Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Systemic Mastocytosis Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Systemic Mastocytosis Treatment Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Systemic Mastocytosis Treatment Revenue by Region
  1. 7.1 Global Systemic Mastocytosis Treatment Revenue by Region
  2. 7.1.1 Global Systemic Mastocytosis Treatment Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Systemic Mastocytosis Treatment Revenue by Region (2021-2026)
  4. 7.1.3 Global Systemic Mastocytosis Treatment Revenue by Region (2027-2032)
  5. 7.1.4 Global Systemic Mastocytosis Treatment Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Systemic Mastocytosis Treatment Revenue (2021-2032)
  8. 7.2.2 North America Systemic Mastocytosis Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Systemic Mastocytosis Treatment Revenue (2021-2032)
  11. 7.3.2 Europe Systemic Mastocytosis Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Systemic Mastocytosis Treatment Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Systemic Mastocytosis Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Systemic Mastocytosis Treatment Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Systemic Mastocytosis Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis AG
  2. 8.1.1 Novartis AG Company Information
  3. 8.1.2 Novartis AG Business Overview
  4. 8.1.3 Novartis AG Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis AG Systemic Mastocytosis Treatment Product Portfolio
  6. 8.1.5 Novartis AG Recent Developments
  7. 8.2 AbbVie Inc
  8. 8.2.1 AbbVie Inc Company Information
  9. 8.2.2 AbbVie Inc Business Overview
  10. 8.2.3 AbbVie Inc Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AbbVie Inc Systemic Mastocytosis Treatment Product Portfolio
  12. 8.2.5 AbbVie Inc Recent Developments
  13. 8.3 Stemline Therapeutics Inc
  14. 8.3.1 Stemline Therapeutics Inc Company Information
  15. 8.3.2 Stemline Therapeutics Inc Business Overview
  16. 8.3.3 Stemline Therapeutics Inc Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Stemline Therapeutics Inc Systemic Mastocytosis Treatment Product Portfolio
  18. 8.3.5 Stemline Therapeutics Inc Recent Developments
  19. 8.4 Seattle Genetics Inc
  20. 8.4.1 Seattle Genetics Inc Company Information
  21. 8.4.2 Seattle Genetics Inc Business Overview
  22. 8.4.3 Seattle Genetics Inc Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Seattle Genetics Inc Systemic Mastocytosis Treatment Product Portfolio
  24. 8.4.5 Seattle Genetics Inc Recent Developments
  25. 8.5 Patara Pharma Inc
  26. 8.5.1 Patara Pharma Inc Company Information
  27. 8.5.2 Patara Pharma Inc Business Overview
  28. 8.5.3 Patara Pharma Inc Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Patara Pharma Inc Systemic Mastocytosis Treatment Product Portfolio
  30. 8.5.5 Patara Pharma Inc Recent Developments
  31. 8.6 Deciphera Pharmaceuticals LLC
  32. 8.6.1 Deciphera Pharmaceuticals LLC Company Information
  33. 8.6.2 Deciphera Pharmaceuticals LLC Business Overview
  34. 8.6.3 Deciphera Pharmaceuticals LLC Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Deciphera Pharmaceuticals LLC Systemic Mastocytosis Treatment Product Portfolio
  36. 8.6.5 Deciphera Pharmaceuticals LLC Recent Developments
  37. 8.7 Bristol-Myers Squibb Company
  38. 8.7.1 Bristol-Myers Squibb Company Company Information
  39. 8.7.2 Bristol-Myers Squibb Company Business Overview
  40. 8.7.3 Bristol-Myers Squibb Company Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bristol-Myers Squibb Company Systemic Mastocytosis Treatment Product Portfolio
  42. 8.7.5 Bristol-Myers Squibb Company Recent Developments
  43. 8.8 Blueprint Medicines Corp
  44. 8.8.1 Blueprint Medicines Corp Company Information
  45. 8.8.2 Blueprint Medicines Corp Business Overview
  46. 8.8.3 Blueprint Medicines Corp Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Blueprint Medicines Corp Systemic Mastocytosis Treatment Product Portfolio
  48. 8.8.5 Blueprint Medicines Corp Recent Developments
  49. 8.9 Arog Pharmaceuticals Inc
  50. 8.9.1 Arog Pharmaceuticals Inc Company Information
  51. 8.9.2 Arog Pharmaceuticals Inc Business Overview
  52. 8.9.3 Arog Pharmaceuticals Inc Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Arog Pharmaceuticals Inc Systemic Mastocytosis Treatment Product Portfolio
  54. 8.9.5 Arog Pharmaceuticals Inc Recent Developments
  55. 8.10 AB Science SA
  56. 8.10.1 AB Science SA Company Information
  57. 8.10.2 AB Science SA Business Overview
  58. 8.10.3 AB Science SA Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 AB Science SA Systemic Mastocytosis Treatment Product Portfolio
  60. 8.10.5 AB Science SA Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Systemic Mastocytosis Treatment Value Chain Analysis
  2. 9.1.1 Systemic Mastocytosis Treatment Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Systemic Mastocytosis Treatment Production Mode & Process
  6. 9.2 Systemic Mastocytosis Treatment Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Systemic Mastocytosis Treatment Distributors
  9. 9.2.3 Systemic Mastocytosis Treatment Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst